Get all your news in one place.
100's of premium titles.
One app.
Start reading
Top News
Top News
Health

FDA approves first genetic test to assess opioid addiction risk

FDA approves genetic test for opioid addiction risk.

FDA Approves Genetic Test for Opioid Use Disorder

In a groundbreaking development, the FDA has given the green light to AVERT-D, the first-ever genetic test that can help determine a person's increased risk of opioid use disorder. This test utilizes a simple cheek swab to analyze genetic markers associated with addiction in the brain's reward system. With approximately six million people in the United States aged 12 and older suffering from opioid use disorder, this announcement brings hope in the fight against this major public health crisis.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.